Literature DB >> 30802530

Inconsistent temporal patterns of genetic variation of HCV among high-risk subjects may impact inference of transmission networks.

Rebecca Rose1, Christopher Rodriguez2, James Jarad Dollar2, Susanna L Lamers2, Guido Massaccesi3, William Osburn3, Stuart C Ray3, David L Thomas3, Andrea L Cox3, Oliver Laeyendecker4.   

Abstract

Hepatitis-C Virus (HCV) sequences are often used to establish networks of people who inject drugs (PWID). However, the degree to which within-host evolutionary dynamics affect those inferences has not been carefully studied. Here, we analyzed 702 longitudinally-sampled HCV E1 sequences from 88 HCV+ people who inject drugs (PWID) in the Baltimore Before and After Acute Study of Hepatitis (BBAASH) cohort. Individuals were tested for HCV RNA over multiple visits to the clinic, and the HCV E1 gene was sequenced for HCV+ samples. Genetic clustering was performed on the full set of sequences using a 3% genetic distance threshold to define epidemiological linkage. Maximum-likelihood (ML) phylogenies were inferred to assess evolutionary relationships. We found 22 clusters containing sequences sampled over five or more years (long-term clusters, LTC), of which 17 had >1 subject. In six of the multi-subject LTC, one subject had a sequence sampled >3 years earlier or later than the next-closest subject in the cluster (time-gap LTC). ML trees showed that, in three of the time-gap LTC, two subjects had identical sequences despite 7-10 years separating the sampling times. In four of the time-gap LTC for whom additional data were available, the subject with the later detected shared variant had both different variants and visits with no detectable HCV RNA (RNA-) prior to the appearance of the shared variant. In the subject with the earlier detection of the shared variant, different variants and RNA- visits were also detected in multiple cases subsequent to appearance of the shared variant. Complex patterns of shared viral variation among PWID reflect on-going re-infection, multiple transmission partners, and/or inconsistent detection of viral variants. Our results suggest that transmission events are currently underestimated by analysis of sequences at a single point in time.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Clustering; Epidemiology; Evolutionary dynamics; Evolutionary rate; Phylogeny

Mesh:

Year:  2019        PMID: 30802530      PMCID: PMC6620775          DOI: 10.1016/j.meegid.2019.02.025

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  38 in total

Review 1.  Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.

Authors:  Paul K Nelson; Bradley M Mathers; Benjamin Cowie; Holly Hagan; Don Des Jarlais; Danielle Horyniak; Louisa Degenhardt
Journal:  Lancet       Date:  2011-07-27       Impact factor: 79.321

2.  Identifying Transmission Clusters with Cluster Picker and HIV-TRACE.

Authors:  Rebecca Rose; Susanna L Lamers; James J Dollar; Mary K Grabowski; Emma B Hodcroft; Manon Ragonnet-Cronin; Joel O Wertheim; Andrew D Redd; Danielle German; Oliver Laeyendecker
Journal:  AIDS Res Hum Retroviruses       Date:  2016-12-13       Impact factor: 2.205

3.  Complex patterns of Hepatitis-C virus longitudinal clustering in a high-risk population.

Authors:  Rebecca Rose; Susanna L Lamers; Guido Massaccesi; William Osburn; Stuart C Ray; David L Thomas; Andrea L Cox; Oliver Laeyendecker
Journal:  Infect Genet Evol       Date:  2017-12-16       Impact factor: 3.342

4.  The mode and tempo of hepatitis C virus evolution within and among hosts.

Authors:  Rebecca R Gray; Joe Parker; Philippe Lemey; Marco Salemi; Aris Katzourakis; Oliver G Pybus
Journal:  BMC Evol Biol       Date:  2011-05-19       Impact factor: 3.260

5.  Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection.

Authors:  William O Osburn; Brian E Fisher; Kimberly A Dowd; Giselle Urban; Lin Liu; Stuart C Ray; David L Thomas; Andrea L Cox
Journal:  Gastroenterology       Date:  2009-09-24       Impact factor: 22.682

6.  CD8 epitope escape and reversion in acute HCV infection.

Authors:  Joerg Timm; Georg M Lauer; Daniel G Kavanagh; Isabelle Sheridan; Arthur Y Kim; Michaela Lucas; Thillagavathie Pillay; Kei Ouchi; Laura L Reyor; Julian Schulze zur Wiesch; Rajesh T Gandhi; Raymond T Chung; Nina Bhardwaj; Paul Klenerman; Bruce D Walker; Todd M Allen
Journal:  J Exp Med       Date:  2004-12-20       Impact factor: 14.307

7.  The road to elimination of hepatitis C: analysis of cures versus new infections in 91 countries.

Authors:  Andrew M Hill; Sanjay Nath; Bryony Simmons
Journal:  J Virus Erad       Date:  2017-07-01

8.  Evolution of HIV-1 within untreated individuals and at the population scale in Uganda.

Authors:  Jayna Raghwani; Andrew D Redd; Andrew F Longosz; Chieh-Hsi Wu; David Serwadda; Craig Martens; Joseph Kagaayi; Nelson Sewankambo; Stephen F Porcella; Mary K Grabowski; Thomas C Quinn; Michael A Eller; Leigh Anne Eller; Fred Wabwire-Mangen; Merlin L Robb; Christophe Fraser; Katrina A Lythgoe
Journal:  PLoS Pathog       Date:  2018-07-27       Impact factor: 6.823

9.  The genealogical population dynamics of HIV-1 in a large transmission chain: bridging within and among host evolutionary rates.

Authors:  Bram Vrancken; Andrew Rambaut; Marc A Suchard; Alexei Drummond; Guy Baele; Inge Derdelinckx; Eric Van Wijngaerden; Anne-Mieke Vandamme; Kristel Van Laethem; Philippe Lemey
Journal:  PLoS Comput Biol       Date:  2014-04-03       Impact factor: 4.475

10.  A new evolutionary model for hepatitis C virus chronic infection.

Authors:  Rebecca R Gray; Marco Salemi; Paul Klenerman; Oliver G Pybus
Journal:  PLoS Pathog       Date:  2012-05-03       Impact factor: 6.823

View more
  2 in total

1.  Plasma virome and the risk of blood-borne infection in persons with substance use disorder.

Authors:  Abraham J Kandathil; Andrea L Cox; Kimberly Page; David Mohr; Roham Razaghi; Khalil G Ghanem; Susan A Tuddenham; Yu-Hsiang Hsieh; Jennifer L Evans; Kelly E Coller; Winston Timp; David D Celentano; Stuart C Ray; David L Thomas
Journal:  Nat Commun       Date:  2021-11-25       Impact factor: 17.694

2.  Repeated exposure to heterologous hepatitis C viruses associates with enhanced neutralizing antibody breadth and potency.

Authors:  Nicole Frumento; Alexis Figueroa; Tingchang Wang; Muhammad N Zahid; Shuyi Wang; Guido Massaccesi; Georgia Stavrakis; James E Crowe; Andrew I Flyak; Hongkai Ji; Stuart C Ray; George M Shaw; Andrea L Cox; Justin R Bailey
Journal:  J Clin Invest       Date:  2022-08-01       Impact factor: 19.456

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.